Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 397.30
-9.20 (-2.26%)
At close: Jul 8, 2026
Coloplast Market Cap
Coloplast has a market cap or net worth of 91.53 billion as of July 8, 2026. Its market cap has decreased by -33.60% in one year.
Market Cap
91.53B
Enterprise Value
114.69B
Revenue
28.05B
Ranking
n/a
PE Ratio
43.51
Stock Price
397.30
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 91.53B, an increase of 1,456.64%. That is a compound annual growth rate of 10.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 91.53B | -25.67% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 114.71B |
| Demant | 59.43B |
| ALK-Abelló | 54.06B |
| H. Lundbeck | 41.51B |
| Zealand Pharma | 21.21B |
| Ambu A/S | 17.59B |
| Bavarian Nordic | 14.57B |